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Introduction
Cardiovascular diseases cause over 15 million deaths in the world each year. Nearly 
half (49%) of all deaths from cardiovascular diseases are from coronary heart disease (CHD). 
CHD by itself is the most common cause of death in Europe: accounting yearly for nearly 2 
million deaths in Europe. Death rates from CHD are generally higher in Eastern Europe than 
in Southern and Western Europe.
Coronary heart disease, particularly at young age, is largely influenced by genetic 
variability. The influence of genetic variance on the serum lipids is of great interest; however, 
the heritability data are in part conflicting. Serum total cholesterol (TC), LDL cholesterol 
(LDL-C), and triglyceride (TG) levels are directly correlate, whereas HDL-cholesterol (HDL- 
C) is inversely correlate with cardiovascular risk.
LDL-receptor (LDLR) gene mutations have dramatic effect on circulating LDL-C 
levels in patients with familial hypercholesterolemia, while the influence of the LDLR gene 
on LDL-C concentrations in the general population is less clear. Data on the influence of the 
lipoprotein lipase (LPL) gene locus on lipoprotein and TG levels do not uniformly agree.
Hypertension is a major public health problem, and the treatment of which consumes a 
large portion of the health care budget. Blood pressure itself is a complex variable, influenced 
by multiple interacting physiologic regulatory systems. Clear evidence for familial 
transmission has been discovered for almost 80 years. Some unusual forms of hypertension
would facilitate identification of the functional genes th
multiple genes are likely to be involved. Mapping loci i
of the influence of heredity and environment on various
are inherited as a simple, monogenic trait; however, i
Monozygotic (MZ) and dizygotic (DZ) twins pro
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detrimental serum lipid levels. Results of twin and family studies have shown a substantial 
genetic component of the hypertension, with a heritable variation of 30 to 60%.
Aims and Plans of Experiments
We recruited monozygotic (MZ) and dizygotic (DZ) twins. The inclusion of the MZ 
twins enabled us to estimate heritability of blood lipids and blood pressure for the studied 
population. Furthermore, we performed a sib-pair analysis in the DZ twins, to look for loci 
related to the quantitative traits, serum lipoprotein concentrations and blood pressure. We did 
not conduct a total genome scan in the DZ twins, but rather directed our attention to candidate 
gene loci.
1. We planned to study healthy twin pairs to determine the influence of heredity and 
environment on TC, LDL-C, HDL-C, TG levels and blood pressure values.
2. We planned to examine the linkage between LDLR and LPL genes and lipoprotein 
levels in healthy persons.
3 When we found no linkage at the LPL locus, we directed our attention to the nearby 
macrophage scavenger receptor gene locus.
4. We planned to investigate also the relationship of LPL gene a
LPL gene locus has been identified not only as a^  s
hypertension as well.
5. As candidate gene loci for blood pressure, we se
renin-angiotensin system. The renin gene itself has b
3
the angiotensinogen gene, and the ACE and ATj receptor genes have been associated 
with increased cardiovascular risk.
6. We planned to examine the role of gene loci of monogenic hypertension forms in the 
regulation of normal blood pressure. Liddle syndrome is a monogenic disorder, which 
closely resembles to "low renin" hypertension. The condition is caused by hyperactivity of 
the epithelial amiloride-sensitive sodium channel in the distal renal tubule, leading to salt 
and volume retention. Autosomal-dominant hypertension with brachydactyly resembles 
essential hypertension. The responsible gene has been mapped to chromosome 12p; 
however, the gene has not yet been identified.
7. We planned to investigate the PLA2 locus on chromosome 12 as a candidate locus for 
blood pressure, as described in one previous association study.
8. When we found linkage with the markers about 20 cM centromeric from the PLA2 
gene, we directed our attention to the IGF-1 gene.
9. We then coupled our attention on blood pressure to echocardiographically 
determined cardiac dimensions.
Materials and Methods
Patients and Clinical Investigation
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We recruited 166 pairs of twins (MZ 100 and DZ 66) by advertisement to participate 
in studies involving blood pressure regulation and cardiovascular phenotypes. The subjects 
were all German Caucasians with mean age of 30±12 years. They were recruited from various 
parts of Germany. A written informed consent was obtained from all participants. Each 
participant underwent a medical history and physical examination. None of them had 
hypertension or any other chronic medical illness. Persons with history of familial lipid 
disorders were excluded. Women who were using oral contraceptives or estrogen 
preparations, women >50 years old, and individuals of both sexes who were ingesting lipid 
influencing medication were also excluded from this analysis. It was no significant difference 
between the age, sex, height, weight and body mass index (BMI) of the MZ and DZ twins. 
The BMI was normal in both groups of twins.
Blood pressure was measured after 5 min (2 measurements, 1 min apart) with a 
standardized mercury sphygmomanometer in the sitting position by an experienced physician. 
Two measurements were obtained 2 minutes apart. The same procedure was performed after 
the subjects were supine for 5 minutes and after 5 minutes of upright posture. The mean of the 
2 measurements was used as the blood pressure.
M-mode and two-dimensional echocardiograms were recorded with patients in the 
left-lateral supine position. Interventricular septal thickness and posterior wall thickness were 
measured in all patients.
Blood was obtained from all twins after a 12-hour fast., 
were determined by automated methods. LDL-C concer 
Friedewald equation.
For the determination of zygosity and other 
obtained from all the twins and the parents of the DZ tw'
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Molecular Genetical Methods
From the extracted DNA the zygosity was verified with the use of five highly 
polymorphic short tandem repeat loci.
We examined five highly polymorphic microsatellite markers at LPL - macrophage 
scavenger receptor (MSR) locus, one at the LDLR locus, three at the AT i receptor, two at the 
angiotensinogen, ACE, and renin loci, three at the Liddle syndrome locus and four at the 
autosomal dominant hypertension with brachydactyly locus and sex at the locus of PLA2- 
IGF-1 on chromosome 12.
The oligonucleotides were synthesized, and fluorescent dyes FAM, TET and HEX 
were attached. The microsatellite loci were amplified using standard PCR conditions with a 
final volume of 15 p i The samples were processed in a Gene Amp 9600 thermal cycler. The 
PCR products were pooled before electrophoresis.
A 24-cm, 6% polyacrilamide gele was used for vertical electrophoresis in a 377 DNA 
Sequencer (Applied Biosystems). Thirty-six samples were electrophoresed and detected 
simultaneously by laser. The PCR products were loaded per gel, and electrophoresis was 
performed for eight hours. The 672 Genescan and Genotyper software (Applied Biosystems) 
was used for detection, sizing and allele determinatio
Linkage Analysis
according standard DNA fragments.
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For this linkage study, the DZ pairs were selected and used as ordinary sib-pairs, but 
with the advantage of perfect age matching and reduced environmental variation affecting the 
phenotype. The MZ twins were used to estimate allele frequencies for the markers tested.
We assessed linkage for continuous traits, such as blood pressure, LDL-C, HDL-C, TC 
and TG levels, against candidate gene loci. We accepted p<0.05 to test for significance.
Sib-pair analysis to determine linkage does not require the specification of a genetic 
model. The underlying trait can follow either Mendelian or non-Mendelian modes of 
inheritance. From the four alleles harboured by the parents for a given locus, each child 
randomly inherits two. Thus, a pair of sibs may have inherited either the same or different 
alleles. More specifically, they may share zero, one, or two alleles identical by descent (IBD). 
If the locus under study is a quantitative trait locus (QTL), phenotypic similarity of sibs 
(measured by the covariance) should increase with the number of alleles they share.
We used the single-point Haseman-Elston (H/E) approach as implemented in the 
SIBPAL program of the statistical analysis for genetic epidemiology (SAGE, 1994) package. 
To test for linkage, a linear regression analysis was carried out with the squared trait 
difference as the dependent variable and IBD as the independent variable. A power 
calculation is available for this test.
Analysis of the blood pressure QTLs was done also by a new method using a 
structural equation modelling (SEM) approach as implemented in the MX-package. This
variance of the trait is due to the genetic effect of the
probability of sharing 0, 1, or 2 alleles IBD. Assui
states (sharing 0, 1, or 2 alleles) covariance (Cov) of a
0.5 A2, C ovibdi = 0.5 Q2 + 0.5 A2 and C ovibd2 = Q2 + (
approach is based on variance (Var) - covariance ((
effects (A), and environmental influences (E): Var
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specified estimating Q, A, and E so that the likelihood of the empirical variance-covariance 
matrix of the sibs, weighted by the probability of sharing zero, one, or two alleles identical by 
descent, is maximized. For each sib pair and each locus, the proportion of alleles IBD, based 
on parental genotypes, is calculated using a multipoint approach as implemented in 
MAPMAKER/SIBS. To test for a QTL effect, the difference in model fit for models with and 
without a QTL effect is calculated as a %2 statistic. Since we used a candidate gene approach, 
we accepted p<0.01 to test for significant linkage.
Parameters of the quantitative genetic models were estimated by structural equation 
modelling using the MX program. The variability of any given phenotype (p) within a 
population can be decomposed into genetic influences (A), environmental influences shared 
by the twins within a family (C) and effects of random environment (E): p = aA + cC + eE, 
with a, c and e as the estimated relative influence. For MZ and DZ, the covariance (r) of their 
phenotype is given by: rMz= a2 + c2 and rDz=0.5 a2 + c2.
Heritability analysis in twin studies can estimate additive components of genetic 
variability (estimated as a2) as well as two environmental influences, shared (c2) and 
nonshared (e2). These values estimate the relative amount of the variable’s influence on 
interindividual differences up to a sum of one. Genetic as well environmental effects were 
estimated by the best fitting model as selected by the %2 value. Statistical analysis was 
conducted using the SPSS program. Adjustment of blood pressure values, T £  HQL-C, LDL- 
C and TG levels for sex and age was done by multiple 
unstandardized residuals as the corrected phenotypes.
Results
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Both the blood pressure and lipoprotein levels were normal in the MY and DY twins 
and there were no significant differences between MZ and DZ twins in these parameters. 
Systolic and diastolic blood pressure were heritable. The echocardiographic parameters also 
demonstrated strong evidence for heritability. A major genetic effect was demonstrated for all 
lipid parameters.
A significant linkage relationship was found for HDL-C and TGs with D8S261. 
Similarly, linkage was found for HDL-C and markers near to macrophage scavenger receptor 
locus. On the other hand, no linkage was found between any of the lipid variables and the 
markers nearer to LPL gene locus or the marker of LDLR gene locus. The macrophage 
scavenger receptor (MSR) gene locus and the LPL gene locus are «9 cM (in OMIM database 
»11 cM ) apart from each other.
Markers at the IGF-1, Liddle syndrome, ATi receptor, and renin gene loci gave 
statistically significant evidence for linkage with systolic blood pressure in the SEM analysis. 
Using Haseman-Elston regression, the same loci were either significant or suggestive 
(p<0.05) for systolic blood pressure only in the sitting position. The ACE and LPL loci 
showed a significant relationship to only one of the blood pressure measurements. Thus, the 
results are only suggestive and not definitive. For diastolic blood pressure, the locus for 
autosomal-dominant hypertension and brachydactyly and the renin gene^yere^i.uniti cant 
linked.
Linkage for the markers at the IGF-1 locus and ech
results were highly suggestive. This relationship remain
possible influences of blood pressure on cardiac dimen
gene gave evidence of linkage with the phenotype posteri
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Summary of New Results
1. Important finding of this study are that TC, HDL-C, LDL-C, and TGs are all equally 
influenced by both genetic and environmental influences. The heritability estimates for 
systolic and diastolic blood pressure were high. The echocardiographic parameters also 
demonstrated strong evidence for heritability.
2. Evaluation of the markers suggested lack of linkage between the serum lipid 
concentrations and the LPL gene locus.
3. We were unable to find any linkage between the LDLR gene locus and LDL-C 
concentrations.
4. Our results are the first demonstration of linkage between any serum lipid concentration 
and the macrophage scavenger receptor gene locus.
5. Polymorphic microsatellite markers at the renin gene, the ATi receptor gene, the Liddle 
syndrome gene, and IGF-1 gene loci were linked to the phenotype systolic blood pressure. 
We identified the IGF-1 gene locus and the Liddle syndrome locus as new QTLs for blood 
pressure.
6. Linkage with diastolic blood pressure was found with the reni 
QTL, the locus for autosomal dominant hypertension andjara
7. Linking the IGF-1 gene locus to posterior wall thicknes 
is an important candidate gene for susceptibility to car
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Conclusions
We examined healthy MZ and DZ twins to test for linkage between the LDLR gene 
locus, LPL gene locus, and the macrophage scavenger receptor gene locus and serum lipid 
concentrations. We found evidence for linkage between the macrophage scavenger receptor 
gene locus and serum HDL-C values, as well as a weaker one to TG concentrations, but could 
not find linkage between the LDLR gene locus and serum LDL-C concentrations or between 
the LPL gene locus and the various lipid fractions. The latter observation in no way detracts 
from the results of earlier association studies but may instead be explained by the difference 
in susceptibility gene loci and those loci necessary for disease expression. We suggest that the 
macrophage scavenger receptor gene locus should receive increased attention in terms of 
atherosclerotic risk.
We examined our healthy twins to test for linkage between the seven QTLs, and 
systolic and diastolic blood pressure. We found consistent linkage with the gene loci of renin,
ATI receptor, Liddle syndrome and IGF-1 for systolic blood pressure. Interestingly, linkage 
with diastolic blood pressure was found with the renin locus and the locus for autosomal- 
dominant hypertension and brachydactyly. Both measurements confer the same degree of risk 
in terms of complications. Furthermore, systolic blood pressure can be more consistently and 
accurately measured. The difference of QTLs for systolic and diastoljMDlo^Bttj^Bii^Bnot 
necessarily inconsistent and may instead merely undersco re^K E rt^^^ í^ iy ltb lta /
■S' v ,
W #  REGISTERED O
We suggest that our new findings, namely that Q ^s-dbr blood pressure exist at the
VERSION
Liddle syndrome and IGF-1 loci, may be important to eluMlating mechanism related to these
m  ADDS NO.....— - -  *■» -
diastolic blood pressure regulation.
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observation that the IGF-1 locus is also a QTL for cardiac dimensions suggests that particular 
attention should be directed at the IGF-1 gene.
Because of the high mortality of CVD and hypertension in Hungary it would be very 
important to continue the investigation of the genetical background of these diseases. It would 
be also useful to organize again the twin studies and to get a possibility to continue our study 
in Hungary.
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